HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Osamu Kuromaru Selected Research

MA-2029

8/2009An orally active motilin receptor antagonist, MA-2029, inhibits motilin-induced gastrointestinal motility, increase in fundic tone, and diarrhea in conscious dogs without affecting gastric emptying.
3/2008Oral administration of MA-2029, a novel selective and competitive motilin receptor antagonist, inhibits motilin-induced intestinal contractions and visceral pain in rabbits.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Osamu Kuromaru Research Topics

Disease

1Diarrhea
08/2009
1Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
08/2009
1Visceral Pain
03/2008
1Myocardial Infarction
05/2004
1Coronary Occlusion
05/2004
1Inflammation (Inflammations)
05/2004

Drug/Important Bio-Agent (IBA)

2motilin receptorIBA
08/2009 - 03/2008
2MA-2029IBA
08/2009 - 03/2008
2MotilinIBA
08/2009 - 03/2008
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
05/2004
1Collagenases (Collagenase)FDA Link
05/2004

Therapy/Procedure

1Oral Administration
03/2008
1Intravenous Infusions
03/2008